New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 30, 2014
07:28 EDTBCRXBioCryst price target raised to $24 from $21 at H.C. Wainwright
H.C. Wainwright raised its price target for BioCryst shares to $24 saying two overhangs have been removed with the positive Phase 2a data for oral kallikrein inhibitor 4161 and the recent equity financing. The firm reiterates a Buy rating on the stock.
News For BCRX From The Last 14 Days
Check below for free stories on BCRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 29, 2014
09:22 EDTBCRXOn The Fly: Pre-market Movers
Subscribe for More Information
07:09 EDTBCRXBioCryst receives NIAID funding for non-human primate study of BCX4430
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use